These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 29580941

  • 1. Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.
    Qiu YE, Qin J, Luo Y, Qin SL, Mu YF, Cun R, Jiang HL, Chen JJ, Yu MH, Zhong M.
    Prostaglandins Other Lipid Mediat; 2018 May; 136():9-14. PubMed ID: 29580941
    [Abstract] [Full Text] [Related]

  • 2. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F, Fava C, Jiang H, Zanconato G, Quilley J, Brunelli M, Guglielmi V, Vattemi G, Minuz P.
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [Abstract] [Full Text] [Related]

  • 3. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X, Zhang D, Dou X, Niu N, Huang W, Bai J, Zhang G.
    BMC Cancer; 2014 Nov 18; 14():841. PubMed ID: 25406731
    [Abstract] [Full Text] [Related]

  • 4. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K, Tauber Z.
    Acta Histochem; 2018 Aug 18; 120(6):513-519. PubMed ID: 29908721
    [Abstract] [Full Text] [Related]

  • 5. Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.
    Cizkova K.
    Toxicol Appl Pharmacol; 2018 Sep 15; 355():156-163. PubMed ID: 29960002
    [Abstract] [Full Text] [Related]

  • 6. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE, Elshenawy OH, Abdelrady M, El-Kadi AO.
    Toxicol Lett; 2014 Apr 07; 226(1):53-62. PubMed ID: 24472606
    [Abstract] [Full Text] [Related]

  • 7. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
    Deng Y, Edin ML, Theken KN, Schuck RN, Flake GP, Kannon MA, DeGraff LM, Lih FB, Foley J, Bradbury JA, Graves JP, Tomer KB, Falck JR, Zeldin DC, Lee CR.
    FASEB J; 2011 Feb 18; 25(2):703-13. PubMed ID: 21059750
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
    Chaudhary KR, Zordoky BN, Edin ML, Alsaleh N, El-Kadi AO, Zeldin DC, Seubert JM.
    Prostaglandins Other Lipid Mediat; 2013 Feb 18; 104-105():8-17. PubMed ID: 22922020
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Theken KN, Schuck RN, Edin ML, Tran B, Ellis K, Bass A, Lih FB, Tomer KB, Poloyac SM, Wu MC, Hinderliter AL, Zeldin DC, Stouffer GA, Lee CR.
    Atherosclerosis; 2012 Jun 18; 222(2):530-6. PubMed ID: 22503544
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR, Jang HS, Salem FE, Ferrer FA, Kim J, Padanilam BJ.
    Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F138-F151. PubMed ID: 36475868
    [Abstract] [Full Text] [Related]

  • 14. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
    Chen G, Xu R, Wang Y, Wang P, Zhao G, Xu X, Gruzdev A, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2012 Sep 01; 303(5):E563-75. PubMed ID: 22739108
    [Abstract] [Full Text] [Related]

  • 15. Soluble Epoxide Hydrolase as an Important Player in Intestinal Cell Differentiation.
    Cizkova K, Koubova K, Foltynkova T, Jiravova J, Tauber Z.
    Cells Tissues Organs; 2020 Sep 01; 209(4-6):177-188. PubMed ID: 33588415
    [Abstract] [Full Text] [Related]

  • 16. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T, Dinh JC, Heyward S, Prasad B, Gharib SA, Lemaitre RN, Sotoodehnia N, Totah RA.
    Int J Mol Sci; 2022 Oct 17; 23(20):. PubMed ID: 36293289
    [Abstract] [Full Text] [Related]

  • 17. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y, Blum M, Hoff U, Wesser T, Fechner M, Westphal C, Gürgen D, Catar RA, Philippe A, Wu K, Bubalo G, Rothe M, Weldon SM, Dragun D, Schunck WH.
    PLoS One; 2016 Oct 17; 11(1):e0145645. PubMed ID: 26727266
    [Abstract] [Full Text] [Related]

  • 18. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
    Aliwarga T, Raccor BS, Lemaitre RN, Sotoodehnia N, Gharib SA, Xu L, Totah RA.
    Free Radic Biol Med; 2017 Nov 17; 112():131-140. PubMed ID: 28734877
    [Abstract] [Full Text] [Related]

  • 19. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y, Gao L, Yao B, Huang S, Zhang Y, Liu J, Liu Z, Wang X.
    Life Sci; 2022 Dec 01; 310():121122. PubMed ID: 36309225
    [Abstract] [Full Text] [Related]

  • 20. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
    Fleming I.
    Vascul Pharmacol; 2016 Nov 01; 86():31-40. PubMed ID: 26975734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.